| Expansion of Senior Finance Leadership Team | 24-Nov-2025 | 07:00 | RNS |
| Interim Results and Investor Presentation | 30-Sep-2025 | 07:00 | RNS |
| Asset Purchase Agreement with Destiny Pharma | 22-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results | 18-Sep-2025 | 07:00 | RNS |
| Result of AGM | 30-Jun-2025 | 12:22 | RNS |
| Office move and Related Party Transaction | 30-Jun-2025 | 07:00 | RNS |
| Q-Bot Limited Fundraising | 27-Jun-2025 | 07:00 | RNS |
| TR-1 | 10-Jun-2025 | 13:28 | RNS |
| Notice of AGM and Annual Report & Accounts | 06-Jun-2025 | 15:12 | RNS |
| Director/PDMR Shareholding | 04-Jun-2025 | 14:34 | RNS |
| Preliminary results for the year ended 31 Dec 2024 | 04-Jun-2025 | 07:00 | RNS |
| PDS: Q1 Results and Clinical and Corporate Update | 14-May-2025 | 16:02 | RNS |
| TR-1 | 09-May-2025 | 10:30 | RNS |
| PDS: Q4 Results and Clinical Programs Update | 27-Mar-2025 | 16:46 | RNS |
| PDS: VERSATILE-003 Phase 3 Clinical Trial | 07-Mar-2025 | 16:26 | RNS |
| Currency | UK Pounds |
| Share Price | 52.00p |
| Change Today | 0.90p |
| % Change | 1.76 % |
| 52 Week High | 56.50p |
| 52 Week Low | 36.50p |
| Volume | 24,559 |
| Shares Issued | 27.77m |
| Market Cap | £14.44m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:07 | 6,242 @ 51.33p |
| 14:37 | 3,000 @ 51.33p |
| 14:36 | 2,000 @ 51.33p |
| 13:17 | 9,434 @ 51.33p |
| 12:35 | 1,197 @ 53.00p |
You are here: research